Categories: Technology

Columbus Weekly report on share buyback

Company announcement no. 13/2025

Transactions in the period 21 July 2025 to 25 July 2025
On 30 June 2025, Columbus A/S announced a share buyback programme under which the company will repurchase shares for up to DKK 16m during the period from 30 June 2025 to 11 March 2026, both dates included, as outlined in company
announcement no. 8/2025.

The share buyback programme is executed in accordance with Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (market abuse regulation) and the Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulations.

The following transactions were made under the share buyback programme in the period 21 July 2025 to 25 July 2025:

  Number of shares Average purchase price (DKK) Transaction value (DKK)
Accumulated, last announcement 164,056 10.46 1,716,758.50
21 July 2025 15,000 9.81 147,153.00
22 July 2025 18,000 9.82 176,679.00
23 July 2025 18,000 10.08 181,409.40
24 July 2015 15,000 10.09 151,306.50
25 July 2025 15,000 10.14 152,047.50
Total, 21 July 2025 to 25 July 2025 81,000 9.98 808,595.40
Total accumulated under the programme 245,056 10.31 2,525,353.90

With the transactions stated above, Columbus A/S holds a total of 245,056 own shares, corresponding to 0.19% of the Company’s share capital.

Ib Kunøe                        Søren Krogh Knudsen
Chairman of the Board                CEO & President

For further information, please contact:
CEO & President, Søren Krogh Knudsen, +45 70 20 50 00

GlobeNews Wire

Recent Posts

Xnergy’s PH Series Becomes World’s First 1.5KW Wireless Charger Certified To FCC, UL And CE Standards

SINGAPORE, June 9, 2026 /PRNewswire/ -- Xnergy Autonomous Power Technologies (Xnergy), a Singapore-headquartered leader in…

10 minutes ago

IEP – Record Conflicts Drive Peace to Historic Low as AI warfare surges

LONDON, June 9, 2026 /PRNewswire/ -- The 2026 Global Peace Index (GPI), released today by…

10 minutes ago

Harness Therapeutics Awarded Grant from The Michael J. Fox Foundation for Parkinsons Research to Advance Parkinson’s Disease Programme

June 09, 2026 02:06 ET  | Source: Harness Therapeutics Grant awarded through the Parkinson's Disease…

1 hour ago

Idorsia strengthens financial position with up to CHF 250 million loan from Pharmakon

Ad hoc announcement pursuant to Art. 53 LR Senior secured term loan of up to…

1 hour ago

Rapid Nutrition Featured on CNBC Discussing Key Trends Shaping the Future of Consumer Wellness

CNBC interview explores GLP-1 weight loss adoption, clinically backed nutrition, preventative health and the evolving…

1 hour ago

A New Lease of Life: Stories of Hope, Survivorship and Second Chances with Apollo Hospitals

Cancer changes lives long before it changes medical reports.NEW DELHI , June 8, 2026 /PRNewswire/ --…

5 hours ago